Zoetis Inc. Class A (ZTS)

49.89
0.04 0.08
NYSE
Prev Close 49.85
Open 49.85
Day Low/High 49.57 / 50.03
52 Wk Low/High 37.73 / 50.39
Volume 900.40K
Exchange NYSE
Shares Outstanding 496.20B
Market Cap 24.77B
Div & Yield N.A. (N.A)

Latest News

Analyst: Merck's Fundamentals Don't Warrant Current Valuation

Analyst: Merck's Fundamentals Don't Warrant Current Valuation

BMO Capital Markets downgrades the pharmaceutical giant ahead of Q2 earnings as pricing pressure mounts and other potential headwinds begin to emerge.

Zoetis Stock Is Up to Scratch

Zoetis Stock Is Up to Scratch

Apoquel, the company's anti-itch drug, has been a very strong seller.

Morning Movers: NTDOY, WMT, VIAB, ZTS

Morning Movers: NTDOY, WMT, VIAB, ZTS

U.S. futures look to follow the rally by other world market as Nintendo shares soar.

Today's Momo Momentum Stock To Watch: Zoetis (ZTS)

Today's Momo Momentum Stock To Watch: Zoetis (ZTS)

Trade-Ideas LLC identified Zoetis (ZTS) as a momo momentum candidate

Brazil's Pet Market Shows its Teeth

Brazil's Pet Market Shows its Teeth

Despite some turmoil in Brazil's economy, the country has established itself as one of the fast-growing pet markets in the world. Here's why.

Merck Animal Health Expands in Brazil in Quest to Overtake Zoetis as World Animal Health Leader

Merck Animal Health Expands in Brazil in Quest to Overtake Zoetis as World Animal Health Leader

Buying a 93% stake in Vallée SA for $400 million will enable it to surpass Ourofino SA in the South American nation and enhance its chances of being first globally.

Post-Brexit, a Dog Is an Investor's Best Friend

Post-Brexit, a Dog Is an Investor's Best Friend

When the going gets tough, investors should snuggle up to the stable pet industry.

Here's When to Sell These 5 Toxic Stocks

Here's When to Sell These 5 Toxic Stocks

Here's a technical look at five big stocks that could be toxic to own.

Zoetis To Host Webcast And Conference Call On Second Quarter 2016 Financial Results

Zoetis To Host Webcast And Conference Call On Second Quarter 2016 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Steve Cohen's London Expansion Unfazed by Brexit Vote

Steve Cohen's London Expansion Unfazed by Brexit Vote

Brexit apparently hasn't put a damper on the former SAC Capital chief's comeback.

10 Stocks to Buy Now From the World's Best Stock Pickers

10 Stocks to Buy Now From the World's Best Stock Pickers

Three market-beating mutual fund managers discussed their favorite stocks at the Morningstar Investment Conference this week in Chicago.

Jim Cramer -- Don't Buy Mattress Firm

Jim Cramer -- Don't Buy Mattress Firm

Jim Cramer finds Zoetis and Bristol-Myers more attractive.

Zoetis Shares Won't Play Dead

Charts say this is a great setup with potential.

Zoetis To Participate In The William Blair 36th Annual Growth Stock Conference

Zoetis To Participate In The William Blair 36th Annual Growth Stock Conference

Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 36th Annual Growth Stock Conference on Tuesday, June 14, 2016, in Chicago, Ill.

Jim Cramer's 'Mad Money' Recap: More Rate Hike Talk, More Market Panic

Jim Cramer's 'Mad Money' Recap: More Rate Hike Talk, More Market Panic

Oil and the Federal Reserve have been running the markets, Cramer says.

Cramer's 'Off the Charts': Pet-Care Stocks Are Investors' Best Friends

Cramer's 'Off the Charts': Pet-Care Stocks Are Investors' Best Friends

Pet-care stocks have weathered market instability in recent months, Bob Lang tells Jim Cramer.

Jim Cramer -- Quick Take on 30 Stocks and What Investors Are Missing

Jim Cramer -- Quick Take on 30 Stocks and What Investors Are Missing

This is the final of a two-part series in which Jim Cramer comments on each of the 30 Dow components.

Dogs That Experience Fear And Anxiety In Response To Loud Noise Such As Fireworks, Thunder, And Construction Work Now Have A New Treatment Option With The Launch Of SILEO® (dexmedetomidine Oromucosal Gel), The First And Only Medication Approved By The U.S. Food And Drug Administration (FDA) For Treatment Of Noise Aversion In Dogs. (Photo Credit: Zoetis)

Dogs That Experience Fear And Anxiety In Response To Loud Noise Such As Fireworks, Thunder, And Construction Work Now Have A New Treatment Option With The Launch Of SILEO® (dexmedetomidine Oromucosal Gel), The First And Only Medication Approved By The U.S. Food And Drug Administration (FDA) For Treatment Of Noise Aversion In Dogs. (Photo Credit: Zoetis)

Dogs that experience fear and anxiety in response to loud noise such as fireworks, thunder, and construction work now have a new treatment option with the launch of SILEO® (dexmedetomidine oromucosal gel), the first...

Zoetis To Participate In The Goldman Sachs 37th Annual Global Healthcare Conference

Zoetis To Participate In The Goldman Sachs 37th Annual Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, in Rancho Palos Verdes, Calif.

Zoetis Declares Third Quarter 2016 Dividend

Zoetis Declares Third Quarter 2016 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a third quarter 2016 dividend payable to holders of the company's common stock of $0.

Zoetis Holds Annual Meeting Of Shareholders

Zoetis Holds Annual Meeting Of Shareholders

Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual meeting today in Short Hills, N.

Zoetis (ZTS) Stock Declines as Ackman Trims Stake

Zoetis (ZTS) Stock Declines as Ackman Trims Stake

Zoetis (ZTS) stock is falling in early-afternoon trading as Bill Ackman's Pershing Square reportedly reduces its stake in the company.

May 10 Premarket Briefing: 10 Things You Should Know

May 10 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are rising Monday as oil prices rebound and China's Cabinet approves measures to boost exports.

Jim Cramer's Top Takeaways: Anheuser-Busch, Constellation Brands, Zoetis

Jim Cramer's Top Takeaways: Anheuser-Busch, Constellation Brands, Zoetis

Cramer says Constellation is the best-in-breed beer company and Zoetis is a great stock to own.

Jim Cramer's 'Mad Money' Recap: What to Expect After the Jobs Report

Jim Cramer's 'Mad Money' Recap: What to Expect After the Jobs Report

Growth is important, but too much or too little means trouble for the stock market.

Zoetis Shares Fall Despite Beating Estimates and Boosting Outlook

Zoetis Shares Fall Despite Beating Estimates and Boosting Outlook

The animal health products maker's stock pulled back as its renewed guidance wasn't heartier.

Zoetis Reports First Quarter 2016 Results

Zoetis Reports First Quarter 2016 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2016 and updated its guidance for full year 2016 and full year 2017.

Zoetis To Participate In The BMO Capital Markets 11th Annual Farm To Market Conference

Zoetis To Participate In The BMO Capital Markets 11th Annual Farm To Market Conference

Zoetis Inc. (NYSE:ZTS) will participate in the BMO Capital Markets 11 th Annual Farm to Market Conference on Thursday, May 19, 2016, in New York, N.